The proposed bill amends section 28-405 of the Revised Statutes Cumulative Supplement, 2024, to classify tianeptine as a controlled substance under the Uniform Controlled Substances Act, aiming to regulate its use and distribution due to concerns over potential misuse and health risks. The bill also repeals the original section, indicating a comprehensive update to Nebraska's legal framework regarding controlled substances. By adding tianeptine to the list of controlled substances, the legislation seeks to enhance public health and safety by preventing unauthorized access and misuse, aligning state regulations with broader efforts to manage the risks associated with such substances.

In addition to tianeptine, the bill proposes amendments to the scheduling of various narcotics, stimulants, depressants, and hallucinogens, introducing new substances to the schedules while deleting Serdexmethylphenidate from Schedule IV. It clarifies definitions and classifications of certain substances, ensuring that their salts, isomers, and derivatives are included in the scheduling. The bill also establishes new regulations for ephedrine and certain narcotic drugs, specifying storage and sale criteria, and lists exceptions for specific products. Overall, the legislation aims to enhance regulatory oversight and control over synthetic drugs and other substances, addressing public health concerns related to drug abuse and misuse.

Statutes affected:
Introduced: 28-405